Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee
Amarin Reports Third Quarter 2016 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Third Quarter 2016 Financial Results and Provides Update on Operations
Amarin to Present at the Jefferies 2016 London Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Present at the Jefferies 2016 London Healthcare Conference
Pure EPA Vascepa® (icosapent ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Parameters in Statin-Treated Women with Persistent High Triglycerides Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Pure EPA Vascepa® (icosapent ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Parameters in Statin-Treated Women with Persistent High Triglycerides
Amarin Announces Contractual Reminder of Optional Put to Holders of $15.1 million Principal Amount of Outstanding 3.50% Exchangeable Senior Notes Due 2032 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Contractual Reminder of Optional Put to Holders of $15.1 million Principal Amount of Outstanding 3.50% Exchangeable Senior Notes Due 2032
Amarin Provides Preliminary 2016 Results and 2017 Outlook Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Provides Preliminary 2016 Results and 2017 Outlook
Amarin Announces Debt Restructuring and Related Private Placement of Exchangeable Senior Notes Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Debt Restructuring and Related Private Placement of Exchangeable Senior Notes
Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference
Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017
Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations
